Fusion Pharmaceuticals Inc. Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 61 rows, 2 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2020-06-02: Reporting owner Khuong Chau Quang; Form 4; Security Class B Preferred Shares; Transaction P Open market or private purchase of non-derivative or derivative security.
- 2020-06-02: Reporting owner Christenson Johan; Form 4; Security Class B Preferred Exchangeable Shares; Transaction P Open market or private purchase of non-derivative or derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2020-06-02 | Khuong Chau Quang Director | 4 | Class B Preferred Shares Derivative · Indirect · (m) | P Open market or private purchase of non-derivative or derivative security | +5,939,025 11,878,051 owned after | $1.15 | 2020-06-30 | |
| 2020-06-02 | Christenson Johan Director | 4 | Class B Preferred Exchangeable Shares Derivative · Indirect · (m) | P Open market or private purchase of non-derivative or derivative security | +2,856,108 5,712,216 owned after | $1.15 | 2020-06-30 |